Clinical trial Recruiting at 1 site Observational Ages 45 to 60 Women only

Can menopausal hormone therapy affect heart function after menopause?

Official title: Menopausal Hormone Therapy And Neural Control Of Left Ventricular Function

Run by Mayo Clinic · NCT07242391 · Data updated 2026-11-12

This study tests whether menopausal hormone therapy changes how the heart responds to stress in women who are past menopause.

Quick facts

Study typeObservational
Ages45 Years to 60 Years
SexWomen only
Enrollment50 (estimated)
SponsorMayo Clinic
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedAugust 26, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedAugust 27, 2026
Trial IDNCT07242391 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women over 45 who are postmenopausal and either using menopausal hormone therapy or not, with no significant heart disease or CNS-active medications as specified.

Probably not a fit

Women with certain preexisting heart conditions or taking excluded medications may not experience any cardiovascular benefit from the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares left ventricular stroke volume and heart rate responses to bursts of sympathetic nerve activity in menopausal women who use menopausal hormone therapy versus those who do not. Participants are women over 45 years who are postmenopausal and meet specific health criteria. Data are collected at Mayo Clinic in Rochester to explore whether hormone therapy influences cardiac responses in this population. The study does not involve new treatments beyond the existing use of menopausal hormone therapy. Results may help clarify potential cardiovascular effects of hormone therapy after menopause.

Why it matters

Potential benefit: If successful, findings could inform safer use of menopausal hormone therapy with respect to heart function after menopause.

How similar studies have gone: Prior research has explored hormone therapy and cardiovascular effects, but this observational approach addressing sympathetic nerve activity responses is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

• \>45-60\< years of age

Exclusion Criteria

* Male sex
* Females between STRAW+10 stages -5 and 0
* PMF in STRAW+10 stage +2
* PMF using oral hormone therapy
* Females who entered menopause due to a surgical procedure or in response to pharmacotherapy (e.g., gonadotrophin releasing hormone agonists or chemotherapy)
* Heart disease such as hypertropic cardiomyopathy, congenital abnormalities, chronic heart failure, valve disease, and a history of myocardial infarction
* Medications that impact the central nervous system including selective serotonin reuptake inhibitors, anxiolytics, sedatives, anticholinergic agents, dopamine, amphetamines, or wake-promoting agents (e.g., modafinil). Other medications will be evaluated on an individual basis by the PI.
* Cardiovascular medications is also an exclusion criterion which includes those acting on the renin-angiotensin-aldosterone axis, adrenergic receptor antagonists, diuretics, nitrates, and calcium channel antagonists. Other medications will be evaluated on an individual basis by the PI.
* Pregnancy
* COPD
* Diabetes
* CKD
* Raynaud's phenomenon
* Sleep disorders
* Shift workers
* BMI ≥40.0kg/m2
* Use of nicotine-containing products within the two years preceding study visits
* Active cancer treatment

Where it's running

  • Mayo Clinic in Rochester
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.